KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ClearPoint Neuro (CLPT) Shares Issued (2018 - 2025)

ClearPoint Neuro's Shares Issued history spans 12 years, with the latest figure at $3.3 million for Q2 2025.

  • For Q2 2025, Shares Issued rose 120.17% year-over-year to $3.3 million; the TTM value through Sep 2025 reached $19.1 million, up 73653.85%, while the annual FY2024 figure was $16.1 million, N/A changed from the prior year.
  • Shares Issued for Q2 2025 was $3.3 million at ClearPoint Neuro, down from $15.9 million in the prior quarter.
  • Across five years, Shares Issued topped out at $46.8 million in Q1 2021 and bottomed at -$46.3 million in Q4 2021.
  • The 5-year median for Shares Issued is $253000.0 (2022), against an average of $1.5 million.
  • The largest annual shift saw Shares Issued plummeted 6380.0% in 2023 before it surged 5151.27% in 2024.
  • A 5-year view of Shares Issued shows it stood at -$46.3 million in 2021, then soared by 100.01% to $5000.0 in 2022, then tumbled by 6380.0% to -$314000.0 in 2023, then soared by 5151.27% to $15.9 million in 2024, then tumbled by 79.43% to $3.3 million in 2025.
  • Per Business Quant, the three most recent readings for CLPT's Shares Issued are $3.3 million (Q2 2025), $15.9 million (Q4 2024), and $267000.0 (Q3 2024).